These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16114276)

  • 1. Metabolic consequences of GH deficiency.
    Jørgensen JO; Vestergaard E; Gormsen L; Jessen N; Nørrelund H; Christiansen JS; Møller N
    J Endocrinol Invest; 2005; 28(5 Suppl):47-51. PubMed ID: 16114276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and glucose homeostasis.
    Jørgensen JO; Krag M; Jessen N; Nørrelund H; Vestergaard ET; Møller N; Christiansen JS
    Horm Res; 2004; 62 Suppl 3():51-5. PubMed ID: 15539799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
    Trepp R; Stettler C; Diem P; Christ ER
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic implications of growth hormone therapy.
    Perrini S; Carreira MC; Conserva A; Laviola L; Giorgino F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):79-84. PubMed ID: 19020393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men.
    Sjögren K; Leung KC; Kaplan W; Gardiner-Garden M; Gibney J; Ho KK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E364-71. PubMed ID: 17456639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis.
    Nørrelund H; Møller N; Nair KS; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3120-9. PubMed ID: 11443176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.
    Møller N; Jørgensen JO
    Endocr Rev; 2009 Apr; 30(2):152-77. PubMed ID: 19240267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
    Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
    Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment.
    Groop L; Segerlantz M; Bramnert M
    Horm Res; 2005; 64 Suppl 3():45-50. PubMed ID: 16439844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
    Maison P; Balkau B; Souberbielle JC; Cunin P; Vol S; Macquin-Mavier I; Eschwège E;
    Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
    Attallah H; Friedlander AL; Hoffman AR
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.